A high read count does not guarantee reliable evidence if the reads contain low-quality bases or align ambiguously. Base quality reflects confidence in individual nucleotide calls, while mapping quality indicates confidence in read placement. Interpreting depth alongside both measures helps distinguish genuine sequence support from error-prone or misaligned reads, improving confidence in detected variants and genotypes.
The expected variant allele fraction, or the proportion of reads carrying a variant, influences how much coverage is needed to recognize that variant reliably. Variants represented by a smaller fraction of reads are more difficult to separate from sequencing errors. Thresholds should therefore be considered together with allele-fraction expectations rather than treated as universal cutoffs.
The appropriate threshold depends partly on the sequencing design and the regions being measured. Whole-genome, exome, and targeted workflows can produce different coverage distributions, so a single cutoff may not describe data quality equally well across them. Comparing coverage against the intended assay helps identify whether specific genomic regions have adequate support for analysis.
Meeting a minimum depth threshold does not by itself prove that a variant is genuine or that a genotype is correct. Read count must be evaluated with base quality, mapping quality, and variant allele fraction. A position can satisfy the coverage requirement yet remain uncertain if its supporting reads are poor quality or inconsistently aligned.
Analysts examine whether genomic positions meet a selected minimum or target coverage level, then review regions that fall below it. They interpret those results alongside read-level quality measures and variant allele fractions. This process separates well-supported calls from uncertain findings and documents parts of the genome where the data may be insufficient for dependable analysis.
Poorly covered regions should be flagged rather than interpreted with the same confidence as adequately covered positions. Depending on the workflow, the findings can guide additional sequencing to improve coverage in those areas. This approach helps preserve analytical reliability while focusing resources on regions where insufficient data could limit variant detection or genotype confidence.
Higher coverage can provide stronger support for distinguishing true variants from errors, but increasing sequencing depth also requires additional data generation and analysis resources. Lower thresholds may reduce cost while increasing uncertainty in marginal regions. Selecting a suitable target therefore requires balancing the desired analytical sensitivity against practical limits and the reliability needed for the study.